101 related articles for article (PubMed ID: 11299778)
1. Expression of tenascin and fibronectin in benign epithelial hyperplastic lesions and squamous carcinoma of the larynx.
Zidar N; Gale N; Kambic V; Fischinger J
Anticancer Res; 2001; 21(1A):451-4. PubMed ID: 11299778
[TBL] [Abstract][Full Text] [Related]
2. Proliferation of myofibroblasts in the stroma of epithelial hyperplastic lesions and squamous carcinoma of the larynx.
Zidar N; Gale N; Kambic V; Fischinger J
Oncology; 2002; 62(4):381-5. PubMed ID: 12138247
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx.
Kojc N; Zidar N; Vodopivec B; Gale N
Hum Pathol; 2005 Jan; 36(1):16-21. PubMed ID: 15712177
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis of extracellular matrix components in brush biopsies of oral lesions.
Driemel O; Kosmehl H; Rosenhahn J; Berndt A; Reichert TE; Zardi L; Dahse R
Anticancer Res; 2007; 27(3B):1565-70. PubMed ID: 17595777
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast.
Yoshida T; Matsumoto E; Hanamura N; Kalembeyi I; Katsuta K; Ishihara A; Sakakura T
J Pathol; 1997 Aug; 182(4):421-8. PubMed ID: 9306963
[TBL] [Abstract][Full Text] [Related]
6. EB-D fibronectin expression in squamous cell carcinoma of the head and neck.
Mhawech P; Dulguerov P; Assaly M; Ares C; Allal AS
Oral Oncol; 2005 Jan; 41(1):82-8. PubMed ID: 15598590
[TBL] [Abstract][Full Text] [Related]
7. A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Salmas M; Malamou-Mitsi V
BJU Int; 2005 Mar; 95(4):655-9. PubMed ID: 15705098
[TBL] [Abstract][Full Text] [Related]
8. [Expression and pathobiological significance of Col I, Col IV and Fn in laryngeal squamous cell carcinomas].
Zhang H; Li W; Shang W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Dec; 23(24):1130-3. PubMed ID: 20359090
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix proteins expression and incidence of tumor infiltrating cells in laryngeal carcinoma.
Jenek R; Kruk-Zagajewska A; Zeromski J
Pol J Pathol; 1994; 45(3):179-86. PubMed ID: 7953434
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of chondroitin-6-sulphate and tenascin in the larynx: a loss of chondroitin-6-sulphate expression accompanies squamous cell carcinoma invasion.
Uhlman DL; Niehans GA
J Pathol; 1999 Dec; 189(4):470-4. PubMed ID: 10629545
[TBL] [Abstract][Full Text] [Related]
11. Coordinated upregulation of COX-2 and NF-kappaB is a steady feature of laryngeal carcinogenesis.
Kourelis K; Sotiropoulou-Bonikou G; Vandoros G; Repanti M; Varakis I; Goumas P
ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):181-9. PubMed ID: 17264535
[TBL] [Abstract][Full Text] [Related]
12. Distribution and prognostic significance of cell cycle proteins in squamous carcinoma of the larynx, hypopharynx and adjacent epithelial hyperplastic lesions.
Volavsek M; Bracko M; Gale N
J Laryngol Otol; 2003 Apr; 117(4):286-93. PubMed ID: 12816218
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy, cyclin D1, bcl-2 and lymphocytic infiltration of the tumor microenvironment as prognostic factors in laryngeal cancer patients.
Ziółkowski A; Olszewski WP; Gabriel A; Namysłowski G; Kobos J; Morawski K; Urbaniec P
Pol J Pathol; 2005; 56(4):171-8. PubMed ID: 16477876
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic HuR over-expression is associated with increased cyclooxygenase-2 expression in laryngeal squamous cell carcinomas.
Cho NP; Han HS; Soh Y; Lee KY; Son HJ
Pathology; 2007 Dec; 39(6):545-50. PubMed ID: 18027256
[TBL] [Abstract][Full Text] [Related]
15. Analysis of hMSH2 mismatch repair protein expression in dysplasia, carcinoma in situ and invasive squamous cell carcinoma of the vocal folds.
Hussein MR; Aref EE; Yassen DG; Ramadan MO
Cancer Invest; 2009 Jan; 27(1):38-46. PubMed ID: 19160096
[TBL] [Abstract][Full Text] [Related]
16. The interaction of tenascin-C with fibronectin modulates the migration and specific metalloprotease activity in human mesothelioma cell lines of different histotype.
Giuffrida A; Scarpa S; Birarelli P; Modesti A
Int J Oncol; 2004 Sep; 25(3):745-50. PubMed ID: 15289878
[TBL] [Abstract][Full Text] [Related]
17. Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma.
Atula T; Hedström J; Finne P; Leivo I; Markkanen-Leppänen M; Haglund C
Anticancer Res; 2003; 23(3C):3051-6. PubMed ID: 12926160
[TBL] [Abstract][Full Text] [Related]
18. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
19. Characteristic distribution patterns of tenascin in laryngeal and hypopharyngeal cancers.
Juhász A; Bárdos H; Répássy G; Adány R
Laryngoscope; 2000 Jan; 110(1):84-92. PubMed ID: 10646721
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells in precancerous lesions of the larynx.
Sprinzl GM; Hussl B; Obrist P; Yoneda K; Thumfart WF; Romani N; Schrott-Fischer A
Laryngoscope; 2000 Jan; 110(1):13-8. PubMed ID: 10646708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
